CoChat

Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: Possible relevance to ADHD

Open access
Bari, A., Robbins, T. W. · 2013 · Psychopharmacology

The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.

Abstract

RATIONALE: Deficient response inhibition is a prominent feature of many pathological conditions characterised by impulsive and compulsive behaviour. Clinically effective doses of catecholamine reuptake inhibitors are able to improve such inhibitory deficits as measured by the stop-signal task (SST) in humans and other animals. However, the precise therapeutic mode of action of these compounds in terms of their relative effects on dopamine (DA) and noradrenaline (NA) systems in prefrontal cortical and striatal regions mediating attention and cognitive control remains unclear. OBJECTIVES: We sought to fractionate the effects of global catecholaminergic manipulations on SST performance by using receptor-specific compounds for NA or DA. The results are described in terms of the effects of modulating specific receptor subtypes on various behavioural measures such as response inhibition, perseveration, sustained attention, error monitoring and motivation. RESULTS: Blockade of α2-adrenoceptors improved sustained attention and response inhibition, whereas α1 and β1/2 adrenergic receptor antagonists disrupted go performance and sustained attention, respectively. No relevant effects were obtained after targeting DA D1, D2 or D4 receptors, while both a D3 receptor agonist and antagonist improved post-error slowing and compulsive nose-poke behaviour, though generally impairing other task measures. CONCLUSIONS: Our results suggest that the use of specific pharmacological agents targeting α2 and β noradrenergic receptors may improve existing treatments for attentional deficits and impulsivity, whereas DA D3 receptors may modulate error monitoring and perseverative behaviour.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-013-3141-6

Cites

246 of 246 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic illustration of the SST. A standard session consists of 210 trials to be completed within 30 min. On 20 % of the trials (stop trials), a stop-signal will be played after the left lever has been pressed and after a variable stop-signal delay (SSD), which is based on the mean reaction time (mRT) of the subjects on previous sessions: zero delay (ZD), mRT −350 or mRT −150 ms. The stop-signal instructs the animal that the go response to the right lever has to be inhibited in order to obtain the reward. On the remaining 80 % of the trials (go trials), the left and right levers have to be pressed in rapid sequence and the go reaction time (GoRT) has to be shorter than the limited hold (LH; 1.2 s) in order to receive a reward, which is delivered in the central food well (picture modified from Bari et al. 2011)
Fig. 1 Schematic illustration of the SST. A standard session consists of 210 trials to be completed within 30 min. On 20 % of the trials (stop trials), a stop-signal will be played after the left lever has been pressed and after a variable stop-signal delay (SSD), which is based on the mean reaction time (mRT) of the subjects on previous sessions: zero delay (ZD), mRT −350 or mRT −150 ms. The stop-signal instructs the animal that the go response to the right lever has to be inhibited in order to obtain the reward. On the remaining 80 % of the trials (go trials), the left and right levers have to be pressed in rapid sequence and the go reaction time (GoRT) has to be shorter than the limited hold (LH; 1.2 s) in order to receive a reward, which is delivered in the central food well (picture modified from Bari et al. 2011)CC BY-NC · PubMed Central
Fig. 2 Atipamezole (α2 agonist) administration significantly decreased SSRT at 0.3 mg/kg compared with the vehicle condition. There was only a significant main effect of the drug on mRT. Stop and go accuracy were not affected at any of the doses tested. *p < 0.05 vs. vehicle (Veh) condition
Fig. 2 Atipamezole (α2 agonist) administration significantly decreased SSRT at 0.3 mg/kg compared with the vehicle condition. There was only a significant main effect of the drug on mRT. Stop and go accuracy were not affected at any of the doses tested. *p < 0.05 vs. vehicle (Veh) conditionCC BY-NC · PubMed Central
Fig. 3 Administration of the α1 antagonist prazosin resulted in longer mRT at the doses of 0.15 and 0.5 mg/kg. SSRT and stop accuracy were not affected by the drug, while go accuracy was decreased at 0.5 mg/kg compared with vehicle (Veh; **p < 0.01) and to 0.05 mg/kg (*p < 0.05)
Fig. 3 Administration of the α1 antagonist prazosin resulted in longer mRT at the doses of 0.15 and 0.5 mg/kg. SSRT and stop accuracy were not affected by the drug, while go accuracy was decreased at 0.5 mg/kg compared with vehicle (Veh; **p < 0.01) and to 0.05 mg/kg (*p < 0.05)CC BY-NC · PubMed Central
Fig. 4 Propranolol (β 1/2 antagonist) administration caused only a significant main effect on mRT and go accuracy without affecting SSRT or stop accuracy
Fig. 4 Propranolol (β 1/2 antagonist) administration caused only a significant main effect on mRT and go accuracy without affecting SSRT or stop accuracyCC BY-NC · PubMed Central
Fig. 5 The dopamine D1 receptor antagonist SCH 23390 had no effect on any of the main variables of the SST
Fig. 5 The dopamine D1 receptor antagonist SCH 23390 had no effect on any of the main variables of the SSTCC BY-NC · PubMed Central
Fig. 6 The dopamine D2 antagonist sulpiride had no significant effect on SSRT, mRT or go accuracy. The highest dose tested (10 mg/kg) affected significantly stop accuracy, which was higher compared to the 5 mg/kg condition only. *p < 0.05
Fig. 6 The dopamine D2 antagonist sulpiride had no significant effect on SSRT, mRT or go accuracy. The highest dose tested (10 mg/kg) affected significantly stop accuracy, which was higher compared to the 5 mg/kg condition only. *p < 0.05CC BY-NC · PubMed Central
Fig. 7 Administration of the dopamine D3 receptor agonist 7-OH-PIPAT produced strong detrimental effects, specifically on go measures. mRT was longer than vehicle at all the doses tested (p < 0.01) and the highest dose was also different from all the other conditions (p < 0.01). Go accuracy was lower at 1 mg/kg (p < 0.01 compared with all the other conditions) and at 0.3 mg/kg (p < 0.01) compared with vehicle (Veh). **p < 0.01
Fig. 7 Administration of the dopamine D3 receptor agonist 7-OH-PIPAT produced strong detrimental effects, specifically on go measures. mRT was longer than vehicle at all the doses tested (p < 0.01) and the highest dose was also different from all the other conditions (p < 0.01). Go accuracy was lower at 1 mg/kg (p < 0.01 compared with all the other conditions) and at 0.3 mg/kg (p < 0.01) compared with vehicle (Veh). **p < 0.01CC BY-NC · PubMed Central
Fig. 8 Nafadotride (D3 antagonist) significantly increased SSRT at 3 mg/kg compared with vehicle administration (p < 0.05). The same dose produced longer mRT (p < 0.01 compared with vehicle) and lower go accuracy (p < 0.01 compared with all the other conditions). At the dose of 0.3 mg/kg mRT was faster than both 1 (p < 0.05) and 3 mg/kg (p < 0.01). *p < 0.05; **p < 0.01
Fig. 8 Nafadotride (D3 antagonist) significantly increased SSRT at 3 mg/kg compared with vehicle administration (p < 0.05). The same dose produced longer mRT (p < 0.01 compared with vehicle) and lower go accuracy (p < 0.01 compared with all the other conditions). At the dose of 0.3 mg/kg mRT was faster than both 1 (p < 0.05) and 3 mg/kg (p < 0.01). *p < 0.05; **p < 0.01CC BY-NC · PubMed Central
Fig. 9 The dopamine D4 receptor agonist PD-168,077 only affected SSRT which was slower at 5 mg/kg compared with the 0.5 mg/kg condition *p < 0.05
Fig. 9 The dopamine D4 receptor agonist PD-168,077 only affected SSRT which was slower at 5 mg/kg compared with the 0.5 mg/kg condition *p < 0.05CC BY-NC · PubMed Central
Fig. 10 The DA D4 receptor antagonist l-745,870 impaired go accuracy at the dose of 5 mg/kg, which was significantly lower than both vehicle and 0.5 mg/kg.*p < 0.05
Fig. 10 The DA D4 receptor antagonist l-745,870 impaired go accuracy at the dose of 5 mg/kg, which was significantly lower than both vehicle and 0.5 mg/kg.*p < 0.05CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 246 references

Research works printed but not linked: 1

  1. Gioanni Y, Thierry AM, Glowinski J, Tassin JP (1998) Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics. Synapse 30:362–370 · DOI · Paper page

Cited by

See all 105

Metadata

Authors
Bari, A., & Robbins, T. W.
Affiliations
University of Cambridge (GB)
Corresponding author
Bari, A.
Venue
Psychopharmacology
Published
2013-05-17
Volume
230
Issue
1
Pages
89-111
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2262309309
Cited by
105
References
246
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 14 · 2022: 10 · 2021: 6 · 2020: 5 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 13 · 2015: 14 · 2014: 11 · 2013: 2
FWCI
6.54
Type
journal article
Language
en
Open access
Locations
  • Psychopharmacology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust (089589/Z/09/Z, G0001354, 089589)
  • University of Cambridge
  • Medical Research Council (G0001354, 089589/Z/09/Z)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
noradrenergic modulation, dopaminergic modulation, impulsivity, response inhibition, stop-signal task, sustained attention, error monitoring, perseveration, alpha2-adrenoceptors, beta-adrenergic receptors, dopamine D3 receptor, compulsive behaviour, motivation, prefrontal cortex, striatum
MeSH terms
Animals, Attention, Attention Deficit Disorder with Hyperactivity, Behavior, Animal, Corpus Striatum, Dopamine, Impulsive Behavior, Male, Motivation, Norepinephrine, Reaction Time, Receptors, Adrenergic, beta, Receptors, Dopamine, Prefrontal Cortex, Receptors, Adrenergic, alpha-2, Receptors, Dopamine D3, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: Possible relevance to ADHD. https://app.cochat.ai/papers/10.1007/s00213-013-3141-6
The paper
Bari, A., & Robbins, T. W. (2013). Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: Possible relevance to ADHD. Psychopharmacology. https://doi.org/10.1007/s00213-013-3141-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.